Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role of intestinal function in cachexia.

Matthias Pirlich1, Kristina Norman, Herbert Lochs

  • 1Medizinische Klinik, Gastroenterologie, Hepatologie und Endokrinologie, Charité - Universitätsmedizin Berlin, Berlin, Germany. matthias.pirlich@charite.de

Current Opinion in Clinical Nutrition and Metabolic Care
|August 17, 2006
PubMed
Summary

Impaired gut barrier function in chronic diseases like liver cirrhosis and heart failure increases endotoxemia and inflammation, contributing to cachexia. Improving gut barrier function may enhance nutritional status.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Healthy Weight Loss and Target Weight in the Era of Highly Effective Treatment of Patients With Obesity.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Malnutrition-Sarcopenia Syndrome in older adults: Causes, consequences, and countermeasures.

EXCLI journal·2026
Same author

Guidance for the assessment of the dietary intake and gastrointestinal or nutrition impact symptoms etiologic criterion of GLIM: A modified-Delphi study.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Comparing 24 h Urine and Spot Urine Calcium Measurements in Clinical Routine: Accuracy and Limitations.

Journal of clinical medicine·2026
Same author

Guidance for the assessment of the dietary intake and gastrointestinal or nutrition impact symptoms etiologic criterion of Global Leadership Initiative on Malnutrition: A modified-Delphi study.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

Causes of sarcopenia and frailty in people taking GLP1RAs.

Nature reviews. Endocrinology·2026

Area of Science:

  • Gastroenterology
  • Immunology
  • Pathophysiology

Background:

  • Cachexia is a complex metabolic syndrome associated with chronic diseases.
  • The precise mechanisms driving cachexia remain incompletely understood.
  • The gut barrier's role in inflammation and cachexia is an emerging area of research.

Purpose of the Study:

  • To review current research on the gut barrier's role in inflammation and cachexia.
  • To focus on the implications for liver cirrhosis and chronic heart failure.
  • To explore the link between gut permeability, endotoxemia, and cachexia.

Main Methods:

  • Literature review of recent research.
  • Analysis of studies investigating gut barrier function in chronic diseases.

Related Experiment Videos

  • Examination of the relationship between gut permeability, endotoxemia, and inflammatory markers.

    • Main Results:

    • Chronic diseases like liver cirrhosis and heart failure exhibit increased gut permeability and endotoxemia.
    • Elevated levels of proinflammatory cytokines are observed in these conditions.
    • Interventions improving gut barrier function, such as transjugular intrahepatic portosystemic shunt in liver cirrhosis, correlate with improved nutritional status.

    Conclusions:

    • Impaired gut barrier function and increased gut permeability contribute to endotoxin translocation and systemic inflammation.
    • Endotoxemia is a potential trigger for the inflammatory response implicated in cachexia.
    • Therapeutic strategies targeting gut barrier enhancement hold promise for improving nutritional status in cachexia.